Kyntra Bio Change in Payables and Accrued Expense (Quarterly) Analysis

Kyntra Bio, Inc. (KYNB)

8.71 -0.26 (-2.90%) USD | NASDAQ | Jan 23, 16:00

8.71 0.00 (0.00%) After-Hours: 16:14

View Change in Payables and Accrued Expense (Quarterly) for KYNB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Change in Payables and Accrued Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Change in Payables and Accrued Expense (Quarterly) Benchmarks

Start Trial

Assertio Holdings, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Skye Bioscience, Inc.	Upgrade
Theravance Biopharma, Inc.	Upgrade
Myomo, Inc.	Upgrade